Peptides for use as a vaccine and/or treatment for hiv infection

摘要

Novel synthetic polypeptides are provided that represent a neutralizing epitope of the HIV envelope glycoprotein gp 120 that is purportedly involved in the binding of this molecule to its cognate cellular receptor CD4. The polypeptides may be used in vaccine formulations as well as in diagnostic immunoassays, immunotherapy and pharmaceutical compositions.